The FDA recently approved a daily oral version of Wegovy (semaglutide), giving patients an alternative to the weekly injection
SS attended scientific advisory committee meetings for AstraZeneca, Atara, Bristol-Myers-Squibb, Merck, Novartis, Panalgo, Pfizer, and Seqirus and received speaking fees from Boehringer-Ingelheim and Novartis
Purpose-built for physicians GLP-1 agonists semaglutide, liraglutide may help to treat alcohol use disorder Key takeaways: Participants on semaglutide had reduced risk for hospitalization due to preexisting alcohol use disorder, researchers found
Research shows that patients who reach the 2.4 mg weekly maintenance level see greater average weight reduction compared to those who remain at 1 mg or below
You need a syringe with half-unit markings for this level of precision
Because every pharmacy uses different concentrations, different vial sizes, and different B12 formulations